SHARE PURCHASE AGREEMENT

1.  

INTERPRETATION

1.1  

Definitions

(a)  

" Agreement " means this Share Purchase Agreement including all schedules, and all instruments supplemental to or in amendment or confirmation of this Agreement;

(b)  

“ Acquisition ” means the acquisition of Coronus Share by IMC, pursuant to which Coronus will become a wholly-owned subsidiary of IMC;

(c)  

“ Business Day ” means any day excepting a Saturday, Sunday or statutory holiday in Vancouver, British Columbia;

(d)  

" Closing " means the completion of the sale to and purchase by IMC of the Coronus Share under this Agreement;

(e)  

“ Closing Date ” means the date on which the Closing occurs;

(f)  

" Coronus Financial Statements " means the audited financial statements of Coronus for the period ended June 30, 2009;

(g)  

" Coronus Share " means one common share in the capital of Coronus, being all of Coronus' currently issued and outstanding share capital as at the date hereof;

(h)  

" IMC Stock Options " means the stock options of IMC listed in Schedule "A" hereto, being all of the issued and outstanding stock options of IMC as at the date hereof;

(i)  

" Optionees " means, collectively, Thachuk, Kopelman, Holmes, Bogas and Omielan;

(j)  

" OTCBB " means the Over-The-Counter Bulletin Board;

(k)  

" Quarter " means a period commencing on the day immediately following a Quarter End, and finishing on the subsequent Quarter End;

(l)  

" Quarter End " means, in a given year, March 31, June 30, September 30, and December 31 of that year; and

(m)  

" Thachuk Shares " means the balance of 2,262,500 common shares in the capital of IMC held by Thachuk, after giving effect to the Transfer in accordance with this Agreement.

1.2  

Singular, Plural, etc.

1.3  

Deemed Currency

1.4  

Organization and Headings

1.5  

Governing Law

1.6  

Incorporation of Schedules

2.  

PURCHASE AND SALE

2.1  

Purchase and Sale

2.2  

Purchase Price

(a)  

Burgert will sell the Coronus Share to IMC for consideration of IMC issuing 1,000,000 common shares, at a deemed value of $0.05 per common share, (the “ Purchase Shares ”) to Burgert on the Closing Date. If prior to Closing, there shall be a reclassification of IMC's common shares, a change in IMC's common shares into other shares or securities, a subdivision or consolidation of IMC's common shares into a greater or lesser number of common shares, or any other capital reorganization, the respective number of Purchase Shares issued, and their deemed value, shall be adjusted proportionately.

(b)  

Burgert acknowledges that the Purchase Shares will be subject to the Escrow Agreement.

2.3  

Burgert Engagement and Options

(a)  

engage Burgert as a consultant to IMC; and,

(b)  

in consideration for this engagement, issue to Burgert:

(i)  

75,000 stock options entitling Burgert to acquire 75,000 common shares of IMC at a price of $0.13 per share until April 22, 2015; and

(ii)  

100,000 stock options entitling Burgert to acquire 100,000 common shares of IMC at a price of $0.13 per share until March 31, 2016;

2.4  

Share Transfer

(a)  

In consideration of Burgert paying $1.00 to Thachuk, Thachuk will, and does hereby agree to, transfer (the " Transfer ") 1,012,500 common shares in the capital of IMC (the " Transfer Shares ") to Burgert not less than 61 days prior to the Closing Date. If prior to the Transfer, there shall be a reclassification of IMC's common shares, a change in IMC's common shares into other shares or securities, a subdivision or

(b)  

Burgert acknowledges that the Transfer Shares will be subject to the Escrow Agreement.

2.5  

Restrictions on Transfer

(a)  

IMC acknowledges and agrees that as Coronus is not a “reporting issuer” (or equivalent thereof) in any jurisdiction of Canada, the Coronus Share is subject to an indefinite restriction on resale (i.e., a “hold period”) under applicable Canadian securities laws and IMC will not be able to resell the Coronus Share until expiration of the applicable hold period (which hold period will not commence to run until Coronus has become a "reporting issuer" in a jurisdiction of Canada (which Coronus has no obligation to become)) other than in accordance with limited exemptions under applicable securities legislation and regulatory policy.

(b)  

Burgert acknowledges and agrees that the Purchase Shares and the Transfer Shares will be subject to restrictions on resale and transfer in accordance with applicable securities laws.  Burgert further acknowledges and agrees that the Purchase Shares and the Transfer Shares may be subject to additional resale restrictions based upon Burgert’s jurisdiction of residence and the jurisdiction of residence of any proposed transferee of the Purchase Shares or the Transfer Shares, and it is Burgert’s responsibility to find out what these restrictions are and comply with same before selling, transferring or otherwise disposing of the Purchase Shares or the Transfer Shares.  Burgert acknowledges and agrees that the certificates representing the Purchase Shares and the Transfer Shares will bear such legends as is required with respect to any such restrictions on resale and transfer.

2.6  

Escrow Agreement

(a)  

For each $1.00 in revenue earned by Coronus and IMC in a given Quarter, one Escrowed Share will be released to Burgert and one Escrowed Share will be released to Thachuk.

2.7  

Transaction Expenses

2.8  

Confidentiality

(a)  

Unless and until the transactions contemplated in this Agreement have been completed, or this Agreement has been terminated, except with the prior written consent of the other parties, each of the parties hereto and their respective employees, officers, directors, shareholders, agents, advisors and other representatives will hold all information received from the other party in strictest confidence, except such information and documents available to the public or as are required to be disclosed by applicable law.

(b)  

All such information in written form and documents will be returned to the party originally delivering them in the event that the transactions provided for in this Agreement are not consummated.

3.  

REPRESENTATIONS AND WARRANTIES OF CORONUS

3.1  

It has been duly incorporated and organized and is validly subsisting under the laws of Delaware.

3.2  

It has the corporate power to carry on the Business.

3.3  

The authorized capital of Coronus consists of 1,500 shares of no par common voting stock.

3.4  

The Coronus Share represents all of Coronus' current issued and outstanding share capital and has been validly issued and is outstanding in compliance with all applicable corporate laws.

3.5  

The books and records of Coronus fairly and correctly set out and disclose in all material respects, in accordance with generally accepted accounting principles, the financial position of Coronus as at the date hereof, and all material financial transactions of Coronus relating to the Business have been accurately recorded in such books and records.

3.6  

To its knowledge, Coronus is conducting and will continue to conduct the Business in compliance with all applicable laws, rules and regulations of each jurisdiction in which its business is or will be carried on and Coronus is not in material breach of any such laws, rules or regulations in California (being the only jurisdiction in which Coronus carries on or proposes to carry on the Business).

3.7  

It has good right, full corporate power and absolute authority to enter into this Agreement and to perform all of its obligations under this Agreement.

3.8  

It has taken all necessary actions, steps and corporate and other proceedings to approve or authorize, validly and effectively, the entering into, and the execution, delivery and performance of this Agreement and to complete the Acquisition.

3.9  

No action or proceeding has been commenced or filed by or against Coronus which seeks or may lead to receivership, bankruptcy, a consumer proposal or any other similar proceeding in respect of Coronus, the adjustment, compromise or composition of claims against Coronus or the appointment of a trustee, receiver, liquidator, custodian, or other similar officer for Coronus or any portion of its assets. No such action or proceeding has been authorized or is being considered by or on behalf of Coronus and no creditor or equity security holder of Coronus has, to the knowledge of Coronus, threatened to commence or advise that it may commence, any such action or proceeding.

3.10  

There are not any actions, suits or proceedings, pending or threatened against or affecting Coronus, or affecting the Business, at law or in equity, or before or by any federal, state, municipal or other governmental department, commission, board, bureau, agency or instrumentality, domestic or foreign and Coronus is not aware of any existing ground on which any such action, suit or proceeding might be commenced with any reasonable likelihood of success.

3.11  

The Coronus Financial Statements present fairly the assets, liabilities (whether accrued, absolute, contingent or otherwise) and the financial condition of Coronus as at the date thereof and there will not be, as at the Closing Date, any material adverse change in its assets or financial condition or material increase in such liabilities from that shown in the most recent financial statements.

3.12  

Coronus has made full disclosure to IMC of all aspects of the Business and has made all of its books and records available to the representatives of IMC in order to assist IMC in the performance of its due diligence investigations and there are not any material facts in relation to the Business or Coronus that have not been disclosed to IMC.

3.13  

All information, records and data furnished to IMC, its representatives and legal counsel pursuant to this Agreement,